Send us Feedback

Eli Lilly and Company (LLY)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

LLY » Topics » SIGNATURES

This excerpt taken from the LLY 10-K filed Feb 22, 2010.
Signatures
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Eli Lilly and Company
 
By 
/s/  John C. Lechleiter

 		 
John C. Lechleiter, Ph.D., Chairman of the Board,
President, and Chief Executive Officer
 
February 22, 2010
 
 
82

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 22, 2010 by the following persons on behalf of the Registrant and in the capacities indicated.
 
         
Signature   Title
 
 
     
/s/  John C. Lechleiter, Ph.D. 

JOHN C. LECHLEITER, Ph.D.  		  Chairman of the Board, President, and Chief Executive Officer, and a Director (principal executive officer)
     
/s/  Derica W. Rice

DERICA W. RICE 		  Executive Vice President, Global Services and Chief Financial Officer (principal financial officer)
     
/s/  Arnold C. Hanish

ARNOLD C. HANISH 		  Vice President, Finance and Chief Accounting Officer (principal accounting officer)
     
/s/  Ralph Alvarez

RALPH ALVAREZ 		  Director
     
/s/  Sir Winfried Bischoff

SIR WINFRIED BISCHOFF 		  Director
     
/s/  Michael L. Eskew

MICHAEL L. ESKEW 		  Director
     
/s/  Martin S. Feldstein, Ph.D.

MARTIN S. FELDSTEIN, Ph.D. 		  Director
     
/s/  J. Erik Fyrwald

J. ERIK FYRWALD 		  Director
     
/s/  Alfred G. Gilman, M.D., Ph.D.

ALFRED G. GILMAN, M.D., Ph.D. 		  Director
     
/s/  R. David Hoover

R. DAVID HOOVER 		  Director
     
/s/  Karen N. Horn, Ph.D.

KAREN N. HORN, Ph.D. 		  Director
     
/s/  Ellen R. Marram

ELLEN R. MARRAM 		  Director
     
/s/  Douglas R. Oberhelman

DOUGLAS R. OBERHELMAN 		  Director
     
/s/  Franklyn G. Prendergast, M.D., Ph.D.

FRANKLYN G. PRENDERGAST, M.D., Ph.D. 		  Director
     
/s/  Kathi P. Seifert

KATHI P. SEIFERT 		  Director
 
 
83

 

This excerpt taken from the LLY 8-K filed Nov 19, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
November 19, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Corporate Secretary
This excerpt taken from the LLY 8-K filed Oct 14, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
October 14, 2009   By:   Arnold C. Hanish
       
        Name: Arnold C. Hanish
        Title: Vice President and Chief Accounting Officer
This excerpt taken from the LLY 8-K filed Jul 14, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
July 14, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel

This excerpt taken from the LLY 8-K filed Jun 2, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
June 2, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel
This excerpt taken from the LLY 8-K filed Apr 8, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
April 8, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel
These excerpts taken from the LLY 10-K filed Feb 27, 2009.
Signatures
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Signatures


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned
thereunto duly authorized.


 




This excerpt taken from the LLY 8-K filed Feb 18, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
February 18, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel
This excerpt taken from the LLY 8-K filed Feb 5, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
February 5, 2009   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel
These excerpts taken from the LLY 10-K filed Oct 21, 2008.
Signatures
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Signatures


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned
thereunto duly authorized.


 




This excerpt taken from the LLY 8-K filed Mar 13, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
March 13, 2008   By:   /s/ Arnold C. Hanish
       
        Name: Arnold C. Hanish
        Title: Chief Accounting Officer
These excerpts taken from the LLY 10-K filed Feb 29, 2008.
Signatures
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Signatures


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned
thereunto duly authorized.


 




This excerpt taken from the LLY 8-K filed Dec 19, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
December 19, 2007   By:   James B. Lootens
       
        Name: James B. Lootens
        Title: Secretary and Deputy General Counsel
This excerpt taken from the LLY 8-K filed Mar 5, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
March 5, 2007   By:   Arnold C. Hanish
       
        Name: Arnold C. Hanish
        Title: Chief Accounting Officer
This excerpt taken from the LLY 10-K filed Feb 28, 2007.
Signatures
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
This excerpt taken from the LLY 8-K filed Oct 17, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
October 17, 2005   By:   Alecia A. DeCoudreaux
       
        Name: Alecia A. DeCoudreaux
        Title: Secretary and Deputy General Counsel
This excerpt taken from the LLY 8-K filed Sep 20, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
September 20, 2005   By:   Charles E. Golden
       
        Name: Charles E. Golden
        Title: Executive Vice President and Chief Financial Officer
This excerpt taken from the LLY 8-K filed Sep 8, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
September 8, 2005   By:   Thomas W. Grein
       
        Name: Thomas W. Grein
        Title: Vice President and Treasurer
This excerpt taken from the LLY 8-K filed Jun 10, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Eli Lilly and Company
          
June 10, 2005   By:   Thomas W. Grein
       
        Name: Thomas W. Grein
        Title: Vice President and Treasurer

EXCERPTS ON THIS PAGE:

10-K
Feb 22, 2010
8-K
Nov 19, 2009
8-K
Oct 14, 2009
8-K
Jul 14, 2009
8-K
Jun 2, 2009
8-K
Apr 8, 2009
10-K (2 sections)
Feb 27, 2009
8-K
Feb 18, 2009
8-K
Feb 5, 2009
10-K (2 sections)
Oct 21, 2008
8-K
Mar 13, 2008
10-K (2 sections)
Feb 29, 2008
8-K
Dec 19, 2007
8-K
Mar 5, 2007
10-K
Feb 28, 2007
8-K
Oct 17, 2005
8-K
Sep 20, 2005
8-K
Sep 8, 2005
8-K
Jun 10, 2005

RELATED TOPICS for LLY:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki